Multiply your draw volume in mL by 100 our syringe units guide walks through it
It is the active ingredient in brand-name Mounjaro (for diabetes) and Zepbound (for weight loss)
Lack of Human Clinical Trials The majority of BPC-157 research has been conducted in rodents, rabbits, and other animal models
In the Langendonk 2015 NEJM trial of afamelanotide (MT1) in EPP patients, the most common adverse events were nausea, implant site reactions (bruising, pain), and headache
Key findings from SURMOUNT-1 include a mean weight loss of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks
Routine collection and monitoring of electronic patient-reported outcomes (ePROs) provides real-time, actionable patient data, but guidance on their design and implementation in surgical settings for remote symptom monitoring is limited